Related references
Note: Only part of the references are listed.The exosome encapsulatedmicroRNAsas circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein
Suchandrima Ghosh et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
HNF-4α inhibits hepatocellular carcinoma cell proliferation through mir-122-adam17 pathway
Guang Yang et al.
PLOS ONE (2020)
Plasma Small Extracellular Vesicles Derived miR-21-5p and miR-92a-3p as Potential Biomarkers for Hepatocellular Carcinoma Screening
Andrei Sorop et al.
FRONTIERS IN GENETICS (2020)
Profiling the circulating mRNA transcriptome in human liver disease
Aejaz Sayeed et al.
Oncotarget (2020)
Activation of the oncogenic miR-21-5p promotes HCV replication and steatosis induced by the viral core 3a protein
Sophie Clement et al.
LIVER INTERNATIONAL (2019)
Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma
Yurong Wang et al.
CANCER MEDICINE (2018)
Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012
Donna L. White et al.
GASTROENTEROLOGY (2017)
NEAT1 accelerates the progression of liver fibrosis via regulation of microRNA-122 and Kruppel-like factor 6
Fujun Yu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2017)
A Comparative Study of Serum Exosome Isolation Using Differential Ultracentrifugation and Three Commercial Reagents
Inas Helwa et al.
PLOS ONE (2017)
Overexpression of a glucokinase point mutant in the treatment of diabetes mellitus
G. Lu et al.
GENE THERAPY (2016)
miR-92a-3p and MYCBP2 are involved in MS-275-induced and c-myc-mediated TRAIL-sensitivity in melanoma cells
Mario Venza et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Versatile roles of extracellular vesicles in cancer
Nobuyoshi Kosaka et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Histopathological characteristics of glutamine synthetase-positive hepatic tumor lesions in a mouse model of spontaneous metabolic syndrome (TSOD mouse)
Tetsuyuki Takahashi et al.
MOLECULAR AND CLINICAL ONCOLOGY (2016)
RNA-Seq analysis and transcriptome assembly for blackberry (Rubus sp Var. Lochness) fruit
Daniel Garcia-Seco et al.
BMC GENOMICS (2015)
miR-122 is a Unique Molecule with Great Potential in Diagnosis, Prognosis of Liver Disease, and Therapy Both as miRNA Mimic and Antimir
Sharda Thakral et al.
CURRENT GENE THERAPY (2015)
Neonatal streptozotocin treatment causes type 1 diabetes and subsequent hepatocellular carcinoma in DIAR mice fed a normal diet
Hayato Baba et al.
HEPATOLOGY INTERNATIONAL (2014)
Cytoglobin is expressed in hepatic stellate cells, but not in myofibroblasts, in normal and fibrotic human liver
Hiroyuki Motoyama et al.
LABORATORY INVESTIGATION (2014)
Comparison of Hepatocellular Carcinoma miRNA Expression Profiling as Evaluated by Next Generation Sequencing and Microarray
Yoshiki Murakami et al.
PLOS ONE (2014)
Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma
J. Qi et al.
NEOPLASMA (2013)
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver
Shu-hao Hsu et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma
Yoshito Tomimaru et al.
JOURNAL OF HEPATOLOGY (2012)
Comprehensive miRNA Expression Analysis in Peripheral Blood Can Diagnose Liver Disease
Yoshiki Murakami et al.
PLOS ONE (2012)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma
Anna S. Lok et al.
GASTROENTEROLOGY (2010)
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
Xi Chen et al.
CELL RESEARCH (2008)
TIS21 negatively regulates hepatocarcinogenesis by disruption of cyclin B1-Forkhead box M1 regulation loop
Tae Jun Park et al.
HEPATOLOGY (2008)
Effect of in vivo loss of GDF-15 on hepatocellular carcinogenesis
Teresa A. Zimmers et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study
JA Davila et al.
GUT (2005)
Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the US
JM Yuan et al.
CANCER (2004)
Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States
MM Hassan et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2002)
High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: A potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis
V Paradis et al.
HEPATOLOGY (2001)
Metabolic and nutritional considerations in nonalcoholic fatty liver
DG Fong et al.
HEPATOLOGY (2000)
Suppression of apoptosis in C3H mouse liver tumors by activated Ha-ras oncogene
S Frey et al.
CARCINOGENESIS (2000)
Share Paper
